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Abstract
Sonic hedgehog (SHH) and its signaling have been identified in several human cancers,
and increased levels of its expression appear to correlate with disease progression and
metastasis. However, the role of SHH in bone destruction associated with oral squamous
cell carcinomas is still unclear. In this study we analyzed SHH expression and the role
played by SHH signaling in gingival carcinoma-induced jawbone destruction. From an anal-
ysis of surgically resected lower gingival squamous cell carcinoma mandible samples, we
found that SHH was highly expressed in tumor cells that had invaded the bone matrix. On
the other hand, the hedgehog receptor Patched and the signaling molecule Gli-2 were
highly expressed in the osteoclasts and the progenitor cells. SHH stimulated osteoclast for-
mation and pit formation in the presence of the receptor activator for nuclear factor-κB ligand
(RANKL) in CD11b+ mouse bone marrow cells. SHH upregulated phosphorylation of ERK1/
2 and p38 MAPK, NFATc1, tartrate-resistant acid phosphatase (TRAP), and Cathepsin K
expression in RAW264.7 cells. Our results suggest that tumor-derived SHH stimulated the
osteoclast formation and bone resorption in the tumor jawbone microenvironment.
Introduction
Oral squamous cell carcinoma frequently invades into the maxilla and the mandible, and that
is associated with a worse prognosis [1]. Medullary invaded oral squamous cell carcinoma has
been shown to be an independent predictor of reduced overall and disease-specific survival,
and this association appears to result from an increased risk of distant metastatic failure [2].
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Bone resection as a treatment leads to the postoperative disruption of speech and swallowing
function. Therefore, it is critical that a new approach be generated for the treatment of
advanced oral squamous cell carcinoma.
Bone metastatic cancer cells in the bone microenvironment disrupts the bone remodeling
cycle and results in bone destruction [3] [4]. A “vicious cycle” between tumor cells and bone
microenvironment plays a critical role in tumor-mediated osteolysis [5]. Tumor cells produce
osteolytic factors, including parathyroid hormone-related protein (PTHrP) and several inter-
leukins [6]. These factors stimulate the production of the receptor activator of nuclear factor-
κB (RANK) ligand (RANKL) in osteoblast lineage cells, and RANKL triggers osteoclast differ-
entiation via binding to RANK on osteoclast precursors [7]. Bone resorption by mature osteo-
clast releases calcium and growth factors, such as transforming growth factor β (TGF-β) from
the bone matrix, and these growth factors further stimulate tumor growth and the secretion of
osteolytic factors from tumor cells [3] [6].
Hedgehog signaling contributes to the development [8] [9] and progression of many cancers
[10]. During embryonic development, Hedgehog signaling is critical for proper cellular differ-
entiation. The Hedgehog pathway has been associated with organ-specific metastasis to the
bone [11]. Paracrine Hedgehog signaling between tumors and stroma has been shown to sup-
port malignant growth [12]. Heller et al. [13] and other groups [14] [15] [16] [17] have sug-
gested that Hedgehog-targeted therapeutics may be particularly efficient for tumors that arise
within the bone or metastasize to bones due to their effect on host cells within this microenvi-
ronment [18]. Recently, we have revealed that SHH stimulates osteoclast differentiation by
upregulating RANKL expression in bone stromal cells and osteoblasts in the presence of
PTHrP [19] [20]. It is still unclear, however, how Hedgehog signaling participates in osteoclas-
tic bone resorption by oral squamous cell carcinoma cells. In the present study, we analyzed
the effect of SHH expression on advanced oral squamous cell carcinomas and how hedgehog
signaling was involved in osteoclastic bone resorption associated with tumor invasion.
Materials and Methods
Histochemical and immunohistochemical analysis of surgically resected
samples
The study was approved by the Ethical Committee of the Okayama University Graduate School
of Medicine, Dentistry, and Pharmaceutical Sciences (protocol number: 1949), including use of
an advertisement poster in place of patient consent. Written consent was not acquired for this
retrospective study. The authors had access to patients’ records prior to data anonymization.
All the patients were examined and treated at Okayama University Hospital (Okayama, Japan)
between 2000 and 2010, and the diagnosis was clinicopathologically confirmed aggressive inva-
sive phenotype of lower gingival squamous cell carcinoma (n = 10). The surgically resected
mandibles were collected as part of routine care by the authors. No patient had received che-
motherapy and/or radiation therapy before surgery. All patients’ records/information were
anonymised and de-identified prior to analysis. Sections from the deepest part of the invasion
and the boundary between the tumor and the bone were evaluated primarily by light micro-
scopic observation. The sections were deparaffinized, and then autoclaved in 0.2% citrate buffer
for 15 min for antigen retrieval. Sections were incubated with 3% hydrogen peroxide for 30
min to block endogenous peroxidase activity. A primary anti-SHH (rabbit IgG), anti-Gli-2
(rabbit IgG) (Cell Signaling Technology, Danvers, MA), anti-Patched1 (rabbit IgG, Protein-
tech, Chicago IL) and anti-CD68 (mouse IgG, Dako, Glostrup, Denmark) was used for the
immunohistochemical analysis. The specimens were incubated with a 1:100 dilution of the
antibody overnight at 4°C, followed by 3 washes with TBS. The slides were then treated with a
SHH in Bone Destruction
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Abbreviations: TRAP, tartrate-resistant acid
phosphatase; RANKL, receptor activator for nuclear
factor κ B Ligand.
streptoavidin-biotin complex (Envision System Labeled Polymer, horse radish peroxidase
(HRP); Dako, Carpinteria, CA) for 60 min at a dilution of 1:100. The immunoreaction was
visualized using a 3,3'-diaminobenzidine (DAB) substrate-chromogen solution (Dako Cytoma-
tion Liquid DAB Substrate Chromogen System, Dako), and counterstaining was performed
with hematoxylin. Finally, the sections were immersed in an ethanol and xylene bath and
mounted for examination.
Cell lines and culture conditions
The murine macrophage RAW264.7 cells from the American Type Culture Collection (ATCC)
were cultured in Dulbecco's Modified Eagle’s Medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum (FBS). CD11b+ bone marrow cells were cultured in α-Modified
Eagle’s Medium (αMEM) with 10% FBS. Both cell types were cultured in an atmosphere of
10% CO2 at 37°C.
Animals and Purification of osteoclast progenitors
Animals were housed in cages under pathogen-free conditions with humane care and anesthe-
sia was performed using pentobarbital 150 mg /kg I.P. to minimize suffering. The experimental
protocols for CD11b+ osteoclast progenitor cells from C57BL/6 mice (Charles River) was
approved by the Ethics Review Committee for Animal Experimentation of the Okayama Uni-
versity Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (protocol num-
ber: 2010291), and the animals for floxed Smoothened mice (Smotm2Amc/J, The Jackson
Laboratory) was approved for IACUC (Institutional Animal Care and Use Committee) of the
Thomas Jefferson University (Authors' Former Institute). CD11b+ osteoclast progenitor cells
were prepared from 5-week-old male C57BL/6 mice or floxed Smoothened mice. Bone marrow
cells were washed twice in 20 ml of ice-cold phosphate-buffered saline (PBS) supplemented
with 0.5% bovine serum albumin (Sigma, St. Louis, MO) and 2 mM EDTA (Sigma). The cell
pellet was resuspended in 80 μl of buffer A per 107 cells, and was incubated with 20 μl of anti-
CD11b magnetic microbeads (Miltenyi Biotec Inc., Auburn, CA). The labeled cells were
washed, resuspended in 500 μl of buffer A per 108 cells, and applied onto MD depletion column
(Miltenyi Biotec Inc., Bergisch Gladbach, Germany) placed in the magnetic field of a Midi-
MACS separation unit (Miltenyi Biotec Inc.). After washing, we removed the column from the
separation unit and eluted CD11b+ cells. To study the direct role of hedgehog signaling in
osteoclastogenesis, we removed smoothened gene in CD11b+ positive osteoclast precursor cells
from floxed Smoothened mice by infecting Cre-recombinase encoding adenovirus (Ad-CMV-
iCre, Vector Biolab, Malvem, PA). Briefly, freshly isolated CD11b+ positive cells were incu-
bated with 100 pfu of Ad-CMV-Cre or control Ad-CMV-GFP (Vector Biolab) for 1 h in ice.
Cells were resuspended every 15 min and then seeded onto the culture plates. Medium was
replaced the next day. Adenovirus infection was confirmed at 70–90% 72 h after infection
under fluorescence microscopy.
Immunoblot analysis
RAW264.7 cells were rinsed once with ice-cold phosphate buffered saline (PBS) and lysed in
an ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, containing 150 mMNaCl, 1% Triton X-100,
1% NP-40, 10 mMNaF, 100 mM leupeptin, 2 mg/ml aprotinin, and 1 mM phenylmethyl sulfo-
nyl fluoride). Cell lysates containing 10 μg of total protein in a lysis buffer were electrophoresed
in 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels and the
proteins were transferred to nylon membranes (Immobilon-P; Millipore Co.). The membranes
were incubated with primary and secondary antibodies according to the ECL
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chemiluminescence protocol (RPN2109; Amersham Biosciences, Buckinghamshire, UK) to
detect secondary antibody binding. Anti-ERK1/2 (rabbit IgG), pERK1/2 (Thy202/Tyr204, rab-
bit IgG), p38 (rabbit IgG), p-p38 (Tyr180/Tyr182, rabbit IgG) were purchased from Cell Sig-
naling Technology Inc. (Danvers, MA). NFATc1 (mouse IgG), Cathepsin K (rabbit IgG),
tartrate-resistant acid phosphatase (TRAP) (rabbit IgG) and actin (goat IgG) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA) primary antibodies were used at a
1:200 dilution, and horseradish peroxidase-conjugated goat anti-rabbit antibodies or goat anti-
mouse IgG were used as the secondary antibodies at a 1:1000 dilution. Image-J software (NIH,
Bethesda, MD) was used to quantify band intensities on Immunoblots and the statistical analy-
sis was performed by Bonferroni multiple comparisons tests.
TRAP staining and osteoclast activity assay
RAW264.7 murine macrophage cells were treated with 50 ng/ml of recombinant mouse
RANKL (PEPROTECH EC, London, UK) for 5 days CD11b+ bone marrow cells and bone
marrow macrophages [21] were cultured with 30 ng/ml M-CSF, (R&D System, Minneapolis,
MN) and 50 ng/ml RANKL in the presence or absence of SHH (R&D System, Minneapolis,
MN) or Cyclopamine (Toronto Chemical Inc., Miltenyi Biotec Inc., Auburn, CA) for 8 days.
The complete medium was changed every 2 days. The cells were then fixed and stained for
TRAP (Sigma) and the number of TRAP-positive multinucleated cells (nuclear number>3) in
each well was counted. For the osteoclast activity assay, CD11b+ bone marrow cells were seeded
on dentin slices that had been placed in 96-well plates (1 slice/well) and were cultured for 5
days in αMEM containing RANKL (50 ng/ml) and M-CSF (30 ng/ml). Then the medium was
changed to αMEM with or without RANKL (50 ng/ml) and SHH (500 ng/ml), and the cells
were incubated for 7 days. A scanning electron microscope (SEM, VE9800; Keyence, Osaka,
Japan) was used to examine the ultrastructure of the dentin slices. The area of pits on the slices
was quantified by imaging analysis (Lumina Vision; Mitani Corporation, Osaka, Japan). The
results were expressed as the mean ± SD of three cultures.
Microarray analysis
RAW264.7 cells were treated with 50 ng/ml RANKL for 3 days, and then cultured with or with-
out 5 μM smoothened agonist (SAG) (Merck Millipore, Parmstadt, Germany) for 24 h. After
the treatment with SAG, total RNAs were isolated using an miRNeasy Mini Kit (Qiagen,
Valencia, CA). Genome-wide gene expression analysis was performed using SuperPrint G3
Mouse GE 8x60K 2 color (Agilent Technologies, Santa Clara, CA) according to the manufac-
turer’s protocol. The arrays were scanned and digitized by Agilent Feature Extraction 10.7.3.1
software (Agilent Technologies). The data was analyzed by GeneSpring GX v.13 (Agilent
Technologies).
Quantitative real-time PCR analysis
Total RNA was isolated according to the manufacturer’s protocol (RNeasy Minikit, Qiagen).
After RNA reverse transcription, 1 μl of each cDNA preparation was PCR-amplified using the
set of primers described below. The tachykinin receptor 3 primmer: 5’-TTGCAGTGGACAGG
TATATG-3’ and 5’-GATGTGGTGGAGGCAGATTT-3’, NFATc1 primer: 5’- CAAGTCTCT
TTCCCCGACATC-3’ and 5’- CTGCCTTCCGTCTCATAGTG-3’. The condition of quantita-
tive real-time PCR (qPCR) were as follows: 40 cycles of 95°C for 30 seconds 60°C for 30 sec-
onds, and 72°C for 30 seconds for tachykinin receptor 3 or 37 cycles of 95°C for 5 seconds and
62°C for 30 seconds for NFATc1. Melting curves were obtained, RT-qPCR was performed on
the chromo4 (MJ Research, Waltham, MA, USA) using a SsoAdvanced Universal SYBR Green
SHH in Bone Destruction
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Supermix (Bio-Rad Laboratories, Inc. Philadelphia, PA), and the data was analyzed by using
ΔΔCT methods.
Statistical analysis
Data were analyzed by using the unpaired Student’s t-test for analysis of two groups, Fisher’s
protected least significant difference (Fisher’s PLSD) and Bonferroni for analysis of multiple
groups. Results were expressed as the mean ± S.D. p< 0.05 was considered statistically
significant.
Results
SHH expression in osteolytic mandibular squamous cell carcinoma
Fig 1 shows representative microscopic images of invasive bone destruction observed in a
patient with oral squamous cell carcinoma in the mandibular region. SHH, Patched, CD68 and
Gli-2 were not detected in the normal lower gingival epithelium (Fig 1A). SHH was highly
expressed in tumor cells that had invaded the bone matrix, and weakly expressed in osteoclasts
(Fig 1B). On the other hand, the hedgehog receptor Patched was highly expressed in the osteo-
clasts and the progenitor cells (Fig 1B). CD68 was detected in both osteoclasts and progenitor
cells (Fig 1B). Gli-2 was expressed in the progenitor cells, and weakly expressed in tumor cells
(Fig 1B). We analyzed additional 9 cases of mandibular squamous cell carcinoma with invasive
bone destruction and observed (i) intense SHH immunoreactivity in tumor cells, (ii) intense
Patched and Gli-2 immunoreactivity in osteoclasts and progenitor cells in all cases (not
shown).
Fig 1. Immunohistochemical staining for Sonic hedgehog (SHH), Patched, CD68 and Gli-2 in normal
epithelium and osteolytic mandibular squamous cell carcinoma. (A) SHH, Patched, CD68 and Gli-2
expression in the normal epithelium at the edges of area were the mandible was resected. Each right photo is
a magnification of the rectangle delimited area of normal epithelium in the corresponding left photo. Scale
bar, 50 μm. (B) SHH, Patched, CD68 and Gli-2 expression in a resected mandible. Scale bar, 50 μm. Arrow:
osteoclast. Arrowhead: osteoclasts progenitor cell.
doi:10.1371/journal.pone.0151731.g001
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Effects of hedgehog proteins on osteoclast formation and resorption
Next, we studied the effect of hedgehog on osteoclastogenesis. To elucidate the effect of SHH in
osteoclast formation, RAW264.7 murine macrophage cells, known as osteoclast precursor
cells, were inoculated onto 96-wells plates at different cell densities and then treated with
increasing concentrations of RANKL with or without SHH for 6 days. The concentration of
SHH for osteoclastogenesis was determined 500 ng/ml by the previous our studies [19], and
the osteoclast formation was evaluated by TRAP staining. SHH alone did not affect osteoclasto-
genesis, but greatly enhanced RANKL-induced osteoclastic cell differentiation (Fig 2A). Next,
we evaluated the effect of hedgehog on CD11b+ osteoclast precursor cells. CD11b+ bone mar-
row cells were maintained in αMEM containing 10% FBS and 30 ng/ml M-CSF, and treated
with or without 50 ng/ml RANKL and 500 ng/ml SHH for 6 days. The cells were then fixed
and stained for TRAP activity, and TRAP cells containing 3 nuclei were counted as osteoclasts
by microscopy (Fig 2B). As seen in RAW264.7 cells, treatment with SHH alone did not induce
osteoclast formation compared to the control values in untreated cultures. As expected,
RANKL treatment did induce formation of TRAP-positive and a small number of multinucle-
ated osteoclastic cells. Strikingly, massive osteoclastogenesis was significantly observed follow-
ing co-treatment with RANKL and SHH (Fig 2B). The data indicate that SHH acts directly on
osteoclast progenitor cells and stimulates RANKL-induced osteoclastogenesis. To analyze the
effect of SHH on osteoclastogenesis, CD11b+ bone marrow cells were treated with or without
500 ng/ml SHH and the hedgehog signaling inhibitor cyclopamine for 6 days. Treatment with
cyclopamine significantly blocked the SHH-induced increase in osteoclastogenesis and brought
Fig 2. Hedgehog stimulated osteoclast formation of RAW264.7 cells, CD11b+ cells in bonemarrow,
and bonemarrowmacrophages. (A) RAW264.7 cells were inoculated onto a 96-well plate at different cell
densities and then treated with increasing concentrations of RANKL +/- SHH for 6 days. Osteoclast formation
was evaluated by TRAP staining. (B and C) CD11b+ cells isolated from the bone marrow of 5-week-old mice
were cultured in the presence of 30 ng/ml M-CSF and 50 ng/ml RANKL with or without 500 ng/ml SHH in
96-well plate for 6 days. Cultures were also treated with or without SHH and hedgehog inhibitor cyclopamine
for 6 days (C). Bone marrow macrophages were cultured with indicated amount of SHH in the presence of 30
ng/ml M-CSF and 50 ng/ml RANKL in 48-well plate for 7 days. TRAP-positive multinucleated cells (nuclear
number > 3) were counted as osteoclasts. The data from a typical experiment are presented. Data are shown
as the mean ± SD. Statistically significant differences (*P < 0.05, **P < 0.01) between the indicated groups
are marked by asterisks.
doi:10.1371/journal.pone.0151731.g002
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it down to the basal level at 6 μM (Fig 2C). We also confirmed the significant dose dependent
effect of SHH on the osteoclastogenesis by using primary isolated bone marrow macrophages
(Fig 2D). To further confirm the role of SHH in osteoclast differentiation, we isolated CD11b+
bone marrow cells from floxed Smoothened mice, infected cells with either Cre recombinase
encoding adenovirus or control adenovirus, and then compared the effect of SHH on RANKL-
induced osteoclastogenesis (S3 Fig). As expected, stimulating effects of SHH on RANKL-
induced osteoclastogenesis were almost completely abolished by ablation of Smoothened (S3
Fig). Then, we analyzed the effect of SHH on the bone resorption activity of mature osteoclasts.
An osteoclast activity assay using CD11b+ bone marrow cells showed that SHH alone did not
stimulate osteoclast resorption, but significantly enhanced the RANKL-induced bone resorp-
tive activity of osteoclasts (Fig 3A and 3B).
Hedgehog signaling in osteoclast differentiation
To define the molecular mechanisms of the SHH effects on osteoclast formation, we examined
the effects of SHH on the signaling pathways in RAW264.7 cells. RANKL stimulated the tran-
sient ERK and p38 phosphorylation at 15 min (Fig 4A). On the other hand, treatment of SHH
with RANKL increased the sustained and synergistically promoted ERK phosphorylation for
30 and 60 min (P< 0.05) and transient p38 phosphorylation for 15 and 30 min (P< 0.01)
compared with the single treatment of RANKL (Fig 4A). Total ERK and p38 levels remained
constant after the treatments (Fig 4A). NFATc1 is a master regulator of RANKL-induced oste-
oclast formation and herein we investigated the effect of SHH on the NFATc1 expression with
Fig 3. SHH stimulated bone resorptive activity of mature osteoclasts. (A) Bone resorptive activity of
mature osteoclasts differentiated from CD11b+ bone marrow cells were evaluated in a dentin slice. The data
from a typical experiment are presented. Similar results were obtained in three separate experiments. (B) The
resorbed areas on the slides were observed under a microscope and measured. The data from a typical
experiment are presented. Data are shown as the mean ± SD. Statistically significant differences
(**P < 0.01) between the indicated groups are marked by asterisks. Scale bar, 100 mm.
doi:10.1371/journal.pone.0151731.g003
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or without RANKL. Our results showed that the expression of NFATc1 in the presence of
RANKL and SHHwas significantly higher than in the presence of RANKL alone for 24 and 48h
(Fig 4B). Immunoblot analysis showed that the TRAP and Cathepsin K protein expressions
induced by RANKL in RAW264.7 cells were stimulated by SHH treatment for 4 days (Fig 4C). To
confirm whether RAW264.7 cells and CD11b+ cells share similar mechanisms for SHH’s effect on
osteoclast formation, Immunoblot and qPCR analysis were performed. SHH with RANKL syner-
gistically promoted ERK and p38 phosphorylation for 30 and 60 min compared with the single
treatment of RANKL in CD11b+ cells (S4A Fig). SHH significantly upregulated the relative
NFATc1 mRNA levels in the presence of RANKL in CD11b+ cells (P< 0.01, S4B Fig).
Hedgehog signaling is involved in osteoclast differentiation and
activation genes
Since SHH appears to play an important role in the differentiation and activation of osteoclasts,
we compared the endogenous expression levels of genes between vehicle- or SAG-treated
RAW264.7 cells by microarray analysis (S5 Fig). When compared with the vehicle-treated sam-
ples, SAG-treated samples showed an elevation of various pathways, most of which were G
protein-coupled receptor (GPCR) pathways (S1 Fig). S2 Fig shows the genes that were changed
more than three times relevant to the top 3 biological pathways depicted in pathway analysis in
S1 Fig. The expression of tachykinin receptor 3 showed the highest upregulation, 9.8-fold over
Fig 4. Effects of SHH onMAP kinase activity and osteoclast differentiation. (A) Detection of p-ERK,
ERK, p-p38, and p38 by immunoblot analysis after RANKL (50 ng/ml) in murine macrophage RAW264.7 cells
with or without SHH (500 ng/ml). (B) Immunoblot analysis of NFATc1 in RAW264.7 cells 0–48 h after RANKL
(30 ng/ml) or SHH (500 ng/ml) treatment. (C) The mature osteoclast-differentiated cells were treated with
SHH (500 ng/ml) or RANKL (30 ng/ml). Protein expression of TRAP and Cathepsin K was analyzed by
immunoblot analysis. Similar results were obtained in three different experiments.
doi:10.1371/journal.pone.0151731.g004
SHH in Bone Destruction
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the control level, in the non-odorant GPCR pathways (S2 Fig). The expression of the chemo-
kine receptor 3 (CCR3) gene in the GPCR2 class A rhodopsin-like pathways and olfactory
receptor 498 in odorant GPCRs were also upregulated compared to the control levels (S2 Fig).
Discussion
In previous studies, we reported on the ability of paracrine hedgehog signaling to increase oral
squamous cell carcinoma growth in bone through the indirect actions of osteoclastogenesis on
bone marrow stromal cells with osteoclast progenitor cells [19]. In the study, we demonstrated
that SHH stimulated osteoclast formation by upregulating the production of RANKL in bone
marrow stromal cells. In addition to the increased expression of RANKL by SHH recreated by
tumor cells, we previously observed a cooperative effect of the PTHrP pathway in osteoblasts
on osteoclastogenesis in the context of SHH treatment [20]. Further, our data in this study sug-
gest that paracrine hedgehog signaling can increase oral squamous cell carcinoma growth
through direct actions on osteoclast progenitor cells. SHH knockdown in SAS cells tumor
engrafts attenuated the recruitment of new vasculature to the tumor, suggesting the involve-
ment of SHH in tumor-associated angiogenesis [19]. Gli-2 expression was recognized in the
microvasculature in the tumor bone microenvironments of resected samples (data not shown).
Gli-2 expression in tumor cells has been associated with aggressive biological phenotypes in
oral squamous cell carcinoma patients and may be used as a biomarker to predict clinical out-
come [22]. The tumor growth mechanism by hedgehog signaling has been thought to be pri-
marily mediated through an autocrine loop that might be required for proliferation and
survival of oral squamous cell carcinoma cells [23]. In this study, Gli-2 was barely expressed in
tumor cells, suggesting that a high level of the ligand SHH can not respond to it in an autocrine
fashion. We hypothesized that the production of SHH by tumor cells would promote a para-
crine signaling pathway and stimulate hedgehog signaling in bone marrow host cells. There-
fore, targeting hedgehog signaling within osteoclasts and the progenitor cells would effectively
block the supply of growth factors for tumor progression.
In the present study, the osteoclasts expressed patched1 and hedgehog signaling in oral
squamous cell carcinoma cells in the jaw. The function of hedgehog signaling in osteoclasts is
uncertain. Heller et al. also reported that disruption of hedgehog signaling inhibited osteoclast
size and number by transducing smoothened fl/fl bone marrow macrophages with a lentivirus
expressing Cre-recombinase [13]. We also observed a decrease in osteoclasts number after
smoothened excision compared to GFP infected control cells. LDE225, smoothened antagonist,
reduced the hedgehog target gene Gli1 and key genes involved in osteoclast differentiation
(NFATc1 and Cathepsin K) [13]. Moreover, blockade of Shh in SAS cells decreased tumor
growth and osteoclast number in a tibial metaphysis mouse model [19]. These results are
agreement with our data that SHH increased protein levels of NFATc1, TRAP and Cathepsin
K. RANKL signaling triggers osteoclasts differentiation, Binding of RANKL to its receptor,
RANK, rapidly activates ERK and p38 MAP kinases. ERK and p38 MAP kinases are essential
for the differentiation and activation of osteoclasts [24]. The activated MAP kinases then lead
to the stimulation of NFATc1 [24]. On the other hand, SHH signaling pathway is closely asso-
ciated with ERK1/2 cascade, which is the downstream effector of many important growth fac-
tors signaling pathways, and is the core of the signaling networks involved in cell proliferation
and differentiation [25] [26]. p38 MAPK activation is proximal to smoothened, and that a sub-
set of receptors is appropriately compartmentalized for signal activation via direct SHH action
[27]. Our data suggested that SHH assist the upregulation of the NFATc1 expression via activa-
tion of ERK and p38, which contribute of RANKL-induced osteoclastogenesis. To identify the
molecular changes that occur when osteoclasts are activated hedgehog signaling, microarray
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analysis were performed. Pathway analysis revealed that most of the pathways were involved
GPCR-related genes. GPCR represent the largest family of membrane receptors. Analysis of
the human genome has revealed that more than 800 genes encode these 7 trans-membrane
receptors [28]. GPCR stimulation regulates actin remodeling, the activity of ion transport pro-
teins, and cell migration [29] [30] [31]. GPCR can induce signaling events through GRKs by a
mechanism involving MAPK [29]. GRK2 and p38 MAPK are regulators of SHH-dependent
signaling and gene regulation [27]. These functions are closely related to the multinucleation of
osteoclasts, formation of the sealing zone and bone resorption. Tachykinin receptor 3 in non-
odorant GPCRs is the most upregulated gene stimulated by hedgehog signaling. The factor is
the receptor of Neurokinin B, which activates osteoclast formation and bone resorption [32].
CCR3 is the most upregulated gene in the GPCR2 class A rhodopsin-like group. CCR3 is
expressed in osteoclast precursors and promotes the differentiation of osteoclast precursors
into mature osteoclasts [33]. We focus on the tachykinin receptor 3 gene which is most upregu-
lated by SAG treatment, it has been confirmed that tachykinin receptor 3 was upregulated by
the treatment of 1 μM SAG and 500 ng/ml SHH about 4.90 and 6.19 times in RAW264.7 cells,
and 4.12 and 4.31 times in CD11b+ bone marrow cells more than control individually by the
qPCR analysis (P< 0.01). Neurokinin B (NKB) is a neuropeptide in the tachykinin family that
acts as a neurotransmitter and neuromodulator in the sensory nerve system and has a high
affinity for tachykinin receptor 3 [34]. Previous study indicated that NKB was expressed by the
peripheral bone tissue and sensory nerve in bone [32]. In oral squamous cell carcinoma
invaded bone destructed site, SHH from tumor cells might upregulate the tachykinin receptor
3 expression in the preosteoclasts and consequently stimulate osteoclasts differentiation indi-
rect manner.
In conclusion, our results showed that SHH and its signaling molecules were frequently
expressed in the tumor bone microenvironment in mandible resected specimens of oral squa-
mous cell carcinoma, and SHH stimulated the differentiation and activation of osteoclasts
directly. These findings strongly suggest that the SHH pathway plays an important role in the
bone destruction in oral squamous cell carcinoma and should be considered a potential thera-
peutic target in the future.
Supporting Information
S1 Fig. Key pathways predicted by Single Experiment Analysis from the gene list including
factors that were increased or reduced more than two-fold following treatment with SAG
in RAW264.7 cells.
(TIF)
S2 Fig. List of selected genes that belong to the top 3 pathways indicated in S1 Fig and were
changed more than three times. The color range corresponds to the value of fold change.
(TIF)
S3 Fig. CD11b+ bone marrow cells were isolated from floxed Smoothened mice, infected
with Cre recombinase encoding adenovirus (Ad-Cre) or control GFP adenovirus (Ad-
GFP), maintained in differentiation medium for three days, and then treated with SHH.
TRAP-positive multinucleated cells (nuclear number> 3) were counted as osteoclasts. The
data from a typical experiment are presented. Data are shown as the mean ± SD. Statistically
significant differences (P< 0.01) between the indicated groups are marked by asterisks.
(TIF)
S4 Fig. (A) Detection of p-ERK, ERK, p-p38, and p38 by immunoblot analysis after RANKL
(50 ng/ml) in murine macrophage CD11b+ cells with or without SHH (500 ng/ml). (B) qPCR
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analysis of NFATc1 in CD11b+ cells 24 h after RANKL (30 ng/μl) with or without SHH (500
ng/ml) treatment.
(TIF)
S5 Fig. Microarray information.
(XLS)
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